【摘 要】
：
目的探讨阿奇霉素治疗支原体肺炎(MP)的临床疗效可行性及安全性。方法经血清学检测肺炎支原体抗体阳性的肺炎病例84例,随机分为两组各42例,治疗组采用阿奇霉素治疗,对照组用
论文部分内容阅读
目的探讨阿奇霉素治疗支原体肺炎(MP)的临床疗效可行性及安全性。方法经血清学检测肺炎支原体抗体阳性的肺炎病例84例,随机分为两组各42例,治疗组采用阿奇霉素治疗,对照组用红霉素治疗,观察治疗前后患者症状,肺部体征的变化及不良反应。结果治疗组、对照组总有效率分别为95.2%和81.0%,两组比较差异具有统计学意义。结论阿奇霉素治疗支原体肺炎使用安全、简便,疗效好,值得临床推广使用。
Objective To investigate the feasibility and safety of azithromycin in the treatment of mycoplasma pneumonia (MP). Methods Serological detection of Mycoplasma pneumoniae antibody positive cases of 84 cases of pneumonia, were randomly divided into two groups of 42 cases, the treatment group with azithromycin treatment, the control group with erythromycin treatment, observed before and after treatment of patients with symptoms, changes in lung signs and Adverse reactions. Results The total effective rates of the treatment group and the control group were 95.2% and 81.0%, respectively, with significant difference between the two groups. Conclusion Azithromycin safe, simple and effective in the treatment of Mycoplasma pneumonia is worthy of clinical promotion.
其他文献
Background Humoral immunity is an important factor for long-term survival of renal allograft.Here we performed a four-year follow-up to explore the clinical sig
目的 研究转基因表达干扰素-α1(IFN-α1)对乙型肝炎病毒(HBV)的抑制作用.方法 采用分子克隆技术,将HBV全基因插入真核细胞表达载体pBK-CMV中,用FuGENETM6,把pBK-HBV转染人肝癌细胞系SMMC-7721,建立HBV瞬时表达和稳定表达两种细胞模型;导入腺相关病毒载体介导的人IFN-α1重组体(pWP8A-IFN-α1),研究转基因表达IFN-α1对HBV的抑制作用.结果
Background It is necessary to develop some innovative methods to reveal and discover the novel (SLE)-related protein molecules.In the present study,matrix-assis
目的观察步长稳心颗粒联合应用小剂量血管紧张素转换酶抑制剂治疗老年性心律失常、心力衰竭的疗效。方法将96例心律失常、心力衰竭患者随机分为治疗组（步长稳心颗粒加马来酸依
Background Sunitinib has been proved an effective new option for treatment of metastatic renal cell carcinoma (mRCC).Analysis of clinical data of 22 patients,wh
临床观察36例慢性肾功能衰竭患者在接受前列腺素E1治疗后，其尿量、血肌酐、血尿素氮的改变，进一步探讨前列腺素E1用于治疗慢性肾功能衰竭的临床价值。
目的探讨急性创伤性脑损伤(TBI)患者血清Tau蛋白的动态变化及其与认知功能障碍的相关性。方法采用回顾性病例对照研究分析2014年10月— 2016年6月收治的95例急性TBI患者(TBI组)的临床资料，其中男61例，女34例；年龄16～65岁[(40.7±13.6)岁]。格拉斯哥昏迷评分(GCS) 3～8分9例，9～12分11例，13～15分75例。正常对照组为30例健康体检者。分别于TBI后1
目的观察奥扎格雷钠联用纤溶酶治疗急性进展型脑梗死的疗效。方法对64例急性进展型脑梗死患者,随机分为治疗组和对照组。对照组用奥扎格雷钠,治疗组奥扎格雷钠联用纤溶酶,两